Doctors do not recommend using Molnupiravir during pregnancy. Preliminary research showed possibility of fetal harm when administered to pregnant woman. Furthermore, healthcare professionals do not recommend breastfeeding while taking Molnupiravir.

You can find all recommendations and precautions at the FDA website.

What is drug evaluation and Research?

Drug evaluation and research is a crucial process in the development and approval of new medications. Scientists and regulators test and study medicines to ensure their safety and effectiveness before administering them to patients.

The evaluation and research process typically involves several stages, including preclinical testing, clinical trials, and regulatory review. In preclinical testing, researchers test the drug in laboratory and animal studies to assess its potential effectiveness and safety. If the results are promising, the drug can proceed to clinical trials.

Clinical trials involve testing the drug in human volunteers to evaluate its safety, dosage, and effectiveness. We conduct these trials in multiple phases, with each phase involving a larger number of participants. We carefully analyze the data collected from these trials to determine the drug’s benefits and potential side effects.

After the trials, the drug maker sends a NDA to the FDA and other regulators when they finish. Regulators analyze trial data and other information to determine whether to approve the drug for sale.

During the evaluation and research process, it is important for drug manufacturers to adhere to strict ethical and scientific standards. The safety and well-being of clinical trial participants are very important, and the data collected must be accurate and trustworthy.

In summary, drug evaluation and research is a comprehensive process that involves preclinical testing, clinical trials, and regulatory review. In summary, drug evaluation and research is a comprehensive process that involves preclinical testing, clinical trials, and regulatory review. Evaluation ensures that new medications like Molnupiravir 200 mg are safe and effective before making them available to the public.

Molnupiravir 200 mg is generally well-tolerated, and side effects are generally mild and infrequent. The most commonly reported side effects in clinical trials were diarrhea, nausea, and dizziness.

However, it is important to note that Molnupiravir may cause birth defects in unborn babies. Therefore, both men and women should use effective birth control after finishing the course of Molnupiravir. Always consult with a qualified medical professional for personalized advice and information regarding any medication.